Science News
from research organizations

Discovering a “ THRIL” that correlates with severity of Kawasaki disease

Date:
December 26, 2013
Source:
Sanford-Burnham Medical Research Institute
Summary:
A new study discovers a molecule termed "THRIL" that regulates TNF-alpha.
Share:
       
FULL STORY

Sanford-Burnham Medical Research Institute scientists have discovered a new molecule that forms when certain white blood cells -- macrophages -- are stimulated in response to pathogens. The molecule, termed "THRIL," helps regulate the immune response and shows an association with Kawasaki disease. The findings suggest that THRIL may contribute to other inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

The study, published online in Proceedings of the National Academy of Sciences, measured large intergenic noncoding RNA (lincRNA) produced when the immune system is activated. One lincRNA was found to bind heterogenous nuclear ribonucleoprotein L (hnRNPL), creating a new molecule that regulates genetic control of TNF-alpha -- a potent cytokine that promotes inflammation. The authors named the molecule THRIL, after TNF-alpha and hnRNPL-related immunoregulatory lincRNA.

Noncoding RNAs as key regulators of immune response

Large noncoding RNA corresponds to the parts of the genome that do not code for protein.

"For some time we have known that noncoding regions of RNA play important roles in regulating the immune response to microbial pathogens," said Tariq Rana, Ph.D., senior author of the study and professor in the Sanford Children's Health Research Center and director of the RNA Biology Program at Sanford-Burnham. "When we realized that THRIL functioned to control the TNF-alpha gene, we wanted to see if it mirrors the progression in inflammatory diseases."

Collaborating with Jane Burns, M.D., professor of pediatrics at Rady Children's Hospital and UC San Diego, Rana's team measured THRIL levels in Kawasaki disease samples at different stages of the disease, and found that levels were at their lowest during the acute stage of the disease -- when TNF-alpha levels are at their highest.

The findings suggest that THRIL could be a novel biomarker for immune activation and a potential target for inflammatory diseases.


Story Source:

The above post is reprinted from materials provided by Sanford-Burnham Medical Research Institute. Note: Materials may be edited for content and length.


Journal Reference:

  1. Z. Li, T.-C. Chao, K.-Y. Chang, N. Lin, V. S. Patil, C. Shimizu, S. R. Head, J. C. Burns, T. M. Rana. The long noncoding RNA THRIL regulates TNF  expression through its interaction with hnRNPL. Proceedings of the National Academy of Sciences, 2013; DOI: 10.1073/pnas.1313768111

Cite This Page:

Sanford-Burnham Medical Research Institute. "Discovering a “ THRIL” that correlates with severity of Kawasaki disease." ScienceDaily. ScienceDaily, 26 December 2013. <www.sciencedaily.com/releases/2013/12/131226181612.htm>.
Sanford-Burnham Medical Research Institute. (2013, December 26). Discovering a “ THRIL” that correlates with severity of Kawasaki disease. ScienceDaily. Retrieved August 28, 2015 from www.sciencedaily.com/releases/2013/12/131226181612.htm
Sanford-Burnham Medical Research Institute. "Discovering a “ THRIL” that correlates with severity of Kawasaki disease." ScienceDaily. www.sciencedaily.com/releases/2013/12/131226181612.htm (accessed August 28, 2015).

Share This Page: